Skip to content

PHARMA DE COCK

Active
Public limited companyfounded 2022active for 3 yearsBruggestraat 78, 8770 Ingelmunster, BelgiumKBO/BCE: BE 0793.509.587
Summary

PHARMA DE COCK has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €193,428 and a net result of €56,674. Equity is growing by about 53% per year across the filed financial years. Its solvency ranks better than 46% of 12,519 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€587,807total assets 2025
Staff
1.1 FTE
Equity
€193,428
Profit
€56,674
Turnover not published (abbreviated or micro format)
Financial health
71 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.6%
Structure
Accounts 1 day early1 of 2 deeds read
Why 71raises riskFounded in 2022lowers riskFigures for financial year 2025 (filed 29-04-2026)Size: 1.1 FTE, total assets €587,807Legal form: public limited companyShow the evidence

Checked score

Score 2025
71 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 54% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Average
Solvency 58+7
equity 32.9% of total assets
Liquidity 37-3
short-term debt 50.7% · cash 9.9%
Profitability 69-18
return on assets 9.6%
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,211 companies, NACE 47, micro)
Last 24 months 11-2024: 1.1% 12-2024: 1.1%● unchanged vs 11-2024 01-2025: 1.1%● unchanged vs 12-2024 02-2025: 1.2%▲ +0.1 percentage points vs 01-2025 03-2025: 1.2%● unchanged vs 02-2025 04-2025: 1.3%▲ +0.1 percentage points vs 03-2025highest value 05-2025: 0.6%▼ -0.7 percentage points vs 04-2025 06-2025: 0.6%● unchanged vs 05-2025 07-2025: 0.6%● unchanged vs 06-2025 08-2025: 0.5%▼ -0.1 percentage points vs 07-2025 09-2025: 0.5%● unchanged vs 08-2025 10-2025: 0.5%● unchanged vs 09-2025lowest value 11-2025: 0.5%● unchanged vs 10-2025 12-2025: 0.5%● unchanged vs 11-2025 01-2026: 0.6%▲ +0.1 percentage points vs 12-2025 02-2026: 0.6%● unchanged vs 01-2026 03-2026: 0.6%● unchanged vs 02-2026 04-2026: 0.6%● unchanged vs 03-2026 05-2026: 0.8%▲ +0.2 percentage points vs 04-2026 06-2026: 0.8%● unchanged vs 05-2026 07-2026: 0.6%▼ -0.2 percentage points vs 06-2026 08-2026: 0.6%● unchanged vs 07-2026 09-2026: 0.6%● unchanged vs 08-2026 10-2026: 0.6%● unchanged vs 09-2026
Credit of up to €13,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.19, compared with 1.09 in 2024, below the usual 1.5; short-term debt: 50.7% and cash: 9.9% of total assets), and 67.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 48% on solvency, 34% on liquidity, 49% on profitability and 84% on growth.

The bankruptcy probability was computed on 16-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Founded in 2022
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Figures for financial year 2025 (filed 29-04-2026)
NBB · annual accounts
lowers risk · Size: 1.1 FTE, total assets €587,807
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Legal form: public limited company
KBO
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 29-04-2026, 1 day ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
1 day early
2024
1 day early
2023
1 day early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 1 day before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 29 April (3 of the last 3 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end17-10-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2022.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Equity above €150,000equity €193,428 ▲41.4%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Equity rose in 2025from €136,754 to €193,428 ▲ 41.4% View
  • Total assets 20253 financial years filed €587,807 View
  • Active since 2022founded 10-11-2022 3 years View

By topic

Financials

Financial year
2025
Total assets
€587,807
Profit
€56,674
Solvency
32.9%
Total assets▲ 10.6%
Net result
20232025
Go to Financials

Timeline

Events
7
Since
2024
Next accounts
by 30-04-2027
  1. 05-03-2025Resignation: Mathias Viaene (director)
  2. 30-09-2024Back to profit
  3. 30-09-2024Equity above €100,000
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
10-11-2022
Year ends
30-09
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.